Onkos Surgical has announced the completion of its 1,000th clinical implantation of the patient-specific My3D pelvic implant, manufactured from 3D-printed titanium alloy. The My3D series, custom-designed based on patient CT data and FDA-approved, is a benchmark product in metal 3D-printed implants for limb-sparing orthopedic oncology. The milestone of over a thousand clinical cases validates the clinical value of titanium alloy powder bed fusion implants in osseointegration and complex anatomical matching, marking the transition of metal 3D-printed implants from "special cases" to "standard treatment options." Value for powder buyers: ① Medical-grade titanium alloy powder (Ti-6Al-4V ELI) is a high-margin niche segment in the powder industry, and the scaling of overseas benchmark products confirms real market demand. ② Domestic orthopedic implant manufacturers are accelerating customized offerings, with oxygen content and batch-to-batch consistency being key procurement criteria for medical-grade powder. ③ It is recommended to monitor the approval pace of NMPA Class III certifications in China to seize the window for domestic medical powder substitution.